Recent RNLX News
- Renalytix Announces Financing with Expected Size of up to $4 Million • GlobeNewswire Inc. • 04/08/2024 11:00:23 AM
- KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD) • GlobeNewswire Inc. • 03/14/2024 11:00:45 AM
- Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 02/15/2024 12:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 12:00:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:31:06 PM
- Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 02/09/2024 02:00:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 12:15:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 12:15:09 PM
- New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease • GlobeNewswire Inc. • 01/10/2024 12:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/29/2023 09:02:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 11/17/2023 09:01:52 PM
- Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024 • GlobeNewswire Inc. • 11/14/2023 12:00:24 PM
- Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14 • GlobeNewswire Inc. • 11/07/2023 12:00:59 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/03/2023 08:04:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 12:00:11 PM
- US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix • GlobeNewswire Inc. • 10/06/2023 11:00:19 AM
- Renalytix Reports Full Year Fiscal 2023 Results • GlobeNewswire Inc. • 09/28/2023 11:00:49 AM
- Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28 • GlobeNewswire Inc. • 09/25/2023 11:00:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:04:50 PM
- Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer • GlobeNewswire Inc. • 09/07/2023 11:00:27 AM
- Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd • GlobeNewswire Inc. • 08/03/2023 11:00:29 AM
- Renalytix Announces Middle East Distribution Agreement with Vector Pharma • GlobeNewswire Inc. • 07/21/2023 11:00:08 AM
- Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions • GlobeNewswire Inc. • 07/07/2023 11:00:47 AM
- Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors • GlobeNewswire Inc. • 07/03/2023 11:00:00 AM
- Renalytix Gets FDA De Novo Marketing Authorization for KidneyIntelX.dkd • Dow Jones News • 06/29/2023 10:58:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM